Did you know - ICON and Pharmacovigilance
 |
ICON Medical Affairs experienced revenue growth of 113% in fiscal year 2006 |
|
Approximately 50% of ICON Medical Affairs business is “stand alone safety” |
|
ICON’s Drug Safety leadership team has more than 40 years combined industry experience |
|
On their very first and only unannounced FDA inspection to date, ICON Medical Affairs did not receive a single observation or finding |
|
ICON is the only CRO of its size that specializes in providing Pharmacovigilance services to small, medium and large Pharmaceutical and Biotech organizations both in U.S. |
|
ICON can provide clients with a Quality person for Pharmacovigilance from both our UK and German offices |
|
ICON has more experience in working in different safety databases than any other CRO |
|
ICON Medical Affairs “globalized” in 2006 and the number of |